Eric Jonasch, Elshad Hasanov, Matthew T. Campbell, Nizar M. Tannir, Rebecca Slack Tidwell, Hyunsoo Hwang, Lauren Michelle Wood, Mashaal Syed, Travis Solley, Sara Fares, Elaine Brooks, Jessica Cazares, Kimberly Allman, Aradhana M. Venkatesan, Devaki Shilpa Surasi. "Phase 1B/2 study of combination
                    <sup>177</sup>
                    Lu girentuximab plus cabozantinib and nivolumab in treatment-naïve patients with advanced clear cell RCC.." Journal of Clinical Oncology (2026). https://doi.org/10.1200/jco.2026.44.7_suppl.tps582